Efg Capital International Corp. Argenx Se Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
A detailed history of Efg Capital International Corp. transactions in Argenx Se stock. As of the latest transaction made, Efg Capital International Corp. holds 960 shares of ARGX stock, worth $571,756. This represents 0.09% of its overall portfolio holdings.
Number of Shares
960Holding current value
$571,756% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
381Shares Held
31.5MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.33 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.09 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.47 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.15 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$900 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...